WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
Opinion
Balancing benefit and burden: rethinking post-polypectomy colonoscopy surveillance strategies
Post-polypectomy colonoscopy surveillance is widely implemented to reduce colorectal cancer incidence and mortality, yet increasing evidence raises concerns about whether current strategies are ...
Absolute risk is the risk of developing a cancer over a certain period of time. Relative risk is the risk one group of people has of developing a cancer compared to the risk of another group. The ...
Evaluation of the utility of genetic risk assessment for disease prevention requires the development of models incorporating both genetic and non-genetic (environmental) risk factors for predicting ...
Although a key function of cancer genetics services is to provide risk information, to date there has been little consistency in the way in which breast cancer risk perception has been measured. The ...
A multi-million-pound landmark “vaccine damage” case is set to take place in London’s High Court. The test case is being pursued by Jamie Scott who suffered a severe brain injury in April 2021 after ...
That sounded big, didn’t it? An 18% greater risk of colorectal cancer from daily consumption of about 2 ounces of processed meat? For many people, what that sounds like is, “Wow, I’ve got an 18% ...
WASHINGTON — By now we've all heard that the Pfizer COVID-19 vaccine has an efficacy rate of 95%, Moderna of 94%, and Johnson & Johnson about 66%; what you may not have known is that rate's technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results